{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:42:38Z","timestamp":1793673758119,"version":"4.5.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04456-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:56:10Z","timestamp":1751381770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MiR-145 encapsulated small extracellular vesicles inhibit colorectal cancer progression by downregulating fascin actin-bundling protein 1 expression"],"prefix":"10.1186","volume":"16","author":[{"given":"Yanxia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanpeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-2720","authenticated-orcid":false,"given":"Zhimin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"4456_CR1","first-page":"678","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris VK, Kennedy EB, Baxter NN III, Cercek ABB, Cho A, Ciombor M, Cremolini KK, Davis C, Deming A. DA Et Al: Treat Metastatic Colorectal Cancer: ASCO Guideline. 2023;41(3):678\u2013700.","journal-title":"DA Et Al: Treat Metastatic Colorectal Cancer: ASCO Guideline"},{"issue":"3","key":"4456_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"Cancer J Clin"},{"issue":"2","key":"4456_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","volume":"158","author":"LH Nguyen","year":"2020","unstructured":"Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020;158(2):291\u2013302.","journal-title":"Gastroenterology"},{"key":"4456_CR4","doi-asserted-by":"crossref","unstructured":"Chen H-N, Shu Y, Liao F, Liao X, Zhang H, Qin Y, Wang Z, Luo M, Liu Q, Xue Z et al. Genomic evolution and diverse models of systemic metastases in colorectal cancer. 2022, 71(2):322\u201332.","DOI":"10.1136\/gutjnl-2020-323703"},{"issue":"21","key":"4456_CR5","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3390\/ijms222111941","volume":"22","author":"HH Hasbullah","year":"2021","unstructured":"Hasbullah HH, Musa M. Gene therapy targeting p53 and KRAS for colorectal Cancer treatment: A myth or the way forward?? Int J Mol Sci. 2021;22(21):11941.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4456_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, Sun B, Chen B, Xiao Z. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol. 2020;18(1):10.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"4456_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ. Micrornas: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522\u201331.","journal-title":"Nat Rev Genet"},{"key":"4456_CR8","doi-asserted-by":"publisher","first-page":"154290","DOI":"10.1016\/j.prp.2022.154290","volume":"242","author":"N Mozammel","year":"2023","unstructured":"Mozammel N, Amini M, Baradaran B, Mahdavi SZB, Hosseini SS, Mokhtarzadeh A. The function of miR-145 in colorectal cancer progression; an updated review on related signaling pathways. Pathol - Res Pract. 2023;242:154290.","journal-title":"Pathol - Res Pract"},{"issue":"1","key":"4456_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1724600818807492","volume":"34","author":"C Li","year":"2019","unstructured":"Li C, Yan G, Yin L, Liu T, Li C, Wang L. Prognostic roles of MicroRNA 143 and MicroRNA 145 in colorectal cancer: A meta-analysis. Int J Biol Mark. 2019;34(1):6\u201314.","journal-title":"Int J Biol Mark"},{"issue":"5","key":"4456_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1158\/1055-9965.EPI-18-0570","volume":"28","author":"L Xu","year":"2019","unstructured":"Xu L, Zhang Y, Tang J, Wang P, Li L, Yan X, Zheng X, Ren S, Zhang M, Xu M. The prognostic value and regulatory mechanisms of microRNA-145 in various tumors: A systematic review and Meta-analysis of 50 studies. Cancer Epidemiol Biomarkers Prev. 2019;28(5):867\u201381.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"4456_CR11","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1038\/s41598-023-31449-3","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Chen B, Yang M, Qian Y, Shen Q, Chen H, Dong Y, Wang L, Jiao J. A three-plasma MiRNA panel predicts the risk of colorectal cancer: a community-based nested case\u2013control study. Sci Rep. 2023;13(1):4196.","journal-title":"Sci Rep"},{"issue":"7","key":"4456_CR12","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1021\/acs.accounts.9b00109","volume":"52","author":"OG de Jong","year":"2019","unstructured":"de Jong OG, Kooijmans SAA, Murphy DE, Jiang L, Evers MJW, Sluijter JPG, Vader P, Schiffelers RM. Drug delivery with extracellular vesicles: from imagination to innovation. Acc Chem Res. 2019;52(7):1761\u201370.","journal-title":"Acc Chem Res"},{"issue":"2","key":"4456_CR13","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbr\u00fcgger U, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"key":"4456_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2023.09.004","volume":"96","author":"J Fyfe","year":"2023","unstructured":"Fyfe J, Dye D, Razak NBA, Metharom P, Falasca M. Immune evasion on the nanoscale: small extracellular vesicles in pancreatic ductal adenocarcinoma immunity. Sem Cancer Biol. 2023;96:36\u201347.","journal-title":"Sem Cancer Biol"},{"issue":"3","key":"4456_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41565-020-0636-2","volume":"15","author":"S Lenzini","year":"2020","unstructured":"Lenzini S, Bargi R, Chung G, Shin JW. Matrix mechanics and water permeation regulate extracellular vesicle transport. Nat Nanotechnol. 2020;15(3):217\u201323.","journal-title":"Nat Nanotechnol"},{"key":"4456_CR16","doi-asserted-by":"publisher","first-page":"113910","DOI":"10.1016\/j.addr.2021.113910","volume":"179","author":"P Fu","year":"2021","unstructured":"Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z. Extracellular vesicles as delivery systems at nano-\/micro-scale. Adv Drug Deliv Rev. 2021;179:113910.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"4456_CR17","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/pharmaceutics15092297","volume":"15","author":"Y Chen","year":"2023","unstructured":"Chen Y, Shi Y, Tao Z. Fluorescence tracking of small extracellular vesicles in vivo. Pharmaceutics. 2023;15(9):2297.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4456_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12951-023-02187-5","volume":"21","author":"P Fu","year":"2023","unstructured":"Fu P, Guo Y, Luo Y, Mak M, Zhang J, Xu W, Qian H, Tao Z. Visualization of MicroRNA therapy in cancers delivered by small extracellular vesicles. J Nanobiotechnol. 2023;21(1):457.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"4456_CR19","doi-asserted-by":"publisher","first-page":"103197","DOI":"10.1016\/j.xpro.2024.103197","volume":"5","author":"Y Chen","year":"2024","unstructured":"Chen Y, Qian H, Mak M, Tao Z. Protocol for isolating and identifying small extracellular vesicles derived from human umbilical cord mesenchymal stem cells. STAR Protocols. 2024;5(3):103197.","journal-title":"STAR Protocols"},{"key":"4456_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.bioactmat.2023.11.008","volume":"33","author":"F Sun","year":"2024","unstructured":"Sun F, Sun Y, Wang X, Zhu J, Chen S, Yu Y, Zhu M, Xu W, Qian H. Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1\u03b1\/EZH2\/PGC-1\u03b1 pathway. Bioactive Mater. 2024;33:444\u201359.","journal-title":"Bioactive Mater"},{"issue":"11","key":"4456_CR21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41587-019-0262-4","volume":"37","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Ma Z, Wang F, Wang X, Yang Y, Liu Y, Zhao X, Li J, Du H, Zhang M, et al. In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles. Nat Biotechnol. 2019;37(11):1322\u201331.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4456_CR22","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1530\/VB-20-0012","volume":"2","author":"D Sawant","year":"2020","unstructured":"Sawant D, Lilly B. MicroRNA-145 targets in cancer and the cardiovascular system: evidence for common signaling pathways. Vasc Biol. 2020;2(1):R115\u201328.","journal-title":"Vasc Biol"},{"issue":"6","key":"4456_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/jbmr.3976","volume":"35","author":"J Urdinez","year":"2020","unstructured":"Urdinez J, Boro A, Mazumdar A, Arlt MJ, Muff R, Botter SM, Bode-Lesniewska B, Fuchs B, Snedeker JG, Gvozdenovic A. The miR\u2010143\/145 cluster, a novel diagnostic biomarker in chondrosarcoma, acts as a tumor suppressor and directly inhibits Fascin\u20101. J Bone Miner Res. 2020;35(6):1077\u201391.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"4456_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.bbrc.2014.03.107","volume":"446","author":"Y Wang","year":"2014","unstructured":"Wang Y, Hu C, Cheng J, Chen B, Ke Q, Lv Z, Wu J, Zhou Y. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. Biochem Biophys Res Commun. 2014;446(4):1255\u201360.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"4456_CR25","doi-asserted-by":"publisher","first-page":"10022","DOI":"10.3390\/ijms241210022","volume":"24","author":"WC Cho","year":"2023","unstructured":"Cho WC, Wong CF, Li KP, Fong AH, Fung KY, Au JS. miR-145 as a potential biomarker and therapeutic target in patients with Non-Small cell lung Cancer. Int J Mol Sci. 2023;24(12):10022.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4456_CR26","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","volume":"52","author":"C Diener","year":"2023","unstructured":"Diener C, Keller A, Meese E. The miRNA\u2013target interactions: an underestimated intricacy. Nucleic Acids Res. 2023;52(4):1544\u201357.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4456_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/jcmm.12358","volume":"18","author":"S-Y Cui","year":"2014","unstructured":"Cui S-Y, Wang R, Chen L-B. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med. 2014;18(10):1913\u201326.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4456_CR28","doi-asserted-by":"publisher","first-page":"152872","DOI":"10.1016\/j.prp.2020.152872","volume":"216","author":"Q Chen","year":"2020","unstructured":"Chen Q, Zhou L, Ye X, Tao M, Wu J. miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3. Pathol - Res Pract. 2020;216(4):152872.","journal-title":"Pathol - Res Pract"},{"issue":"null","key":"4456_CR29","doi-asserted-by":"publisher","first-page":"10799","DOI":"10.2147\/OTT.S216147","volume":"12","author":"X Shen","year":"2019","unstructured":"Shen X, Jiang H, Chen Z, Lu B, Zhu Y, Mao J, Chai K, Chen W. MicroRNA-145 inhibits cell migration and invasion in colorectal Cancer by targeting TWIST. OncoTargets Therapy. 2019;12(null):10799\u2013809.","journal-title":"OncoTargets Therapy"},{"issue":"8","key":"4456_CR30","doi-asserted-by":"publisher","first-page":"e1352","DOI":"10.1002\/ctm2.1352","volume":"13","author":"X He","year":"2023","unstructured":"He X, Zhong X, Fang Y, Hu Z, Chen Z, Wang Y, Huang H, Zhao S, Li D, Wei P. AF9 sustains Glycolysis in colorectal cancer via H3K9ac-mediated PCK2 and FBP1 transcription. Clin Translational Med. 2023;13(8):e1352.","journal-title":"Clin Translational Med"},{"issue":"1","key":"4456_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1186\/s12885-022-10182-6","volume":"22","author":"X Cheng","year":"2022","unstructured":"Cheng X, Shen T, Liu P, Fang S, Yang Z, Li Y, Dong J. mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated Anoikis. BMC Cancer. 2022;22(1):1151.","journal-title":"BMC Cancer"},{"issue":"5","key":"4456_CR32","doi-asserted-by":"publisher","first-page":"e0126890","DOI":"10.1371\/journal.pone.0126890","volume":"10","author":"J-j Chen","year":"2015","unstructured":"Chen J-j, Cai W-y, Liu X-w, Luo Q-c, Chen G, Huang W-f, Li N. Cai J-c: reverse correlation between MicroRNA-145 and FSCN1 affecting gastric Cancer migration and invasion. PLoS ONE. 2015;10(5):e0126890.","journal-title":"PLoS ONE"},{"issue":"9\u201310","key":"4456_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/0963689719861063","volume":"28","author":"L Ma","year":"2019","unstructured":"Ma L, Li L-L. miR-145 contributes to the progression of cervical carcinoma by directly regulating FSCN1. Cell Transplant. 2019;28(9\u201310):1299\u2013305.","journal-title":"Cell Transplant"},{"issue":"1","key":"4456_CR34","first-page":"1298312","volume":"2023","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wu H, Chen Z, Li G, Guo J. LncRNA PTOV1-AS2 promotes Colon cancer progression through the miR-145-5p\/FSCN1 Axis. J Oncol. 2023;2023(1):1298312.","journal-title":"J Oncol"},{"issue":"2","key":"4456_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ymthe.2018.09.018","volume":"27","author":"W Gao","year":"2019","unstructured":"Gao W, Zhang C, Li W, Li H, Sang J, Zhao Q, Bo Y, Luo H, Zheng X, Lu Y, et al. Promoter Methylation-Regulated miR-145-5p inhibits laryngeal squamous cell carcinoma progression by Targeting\u2009<\u2009em\u2009>\u2009FSCN1. Mol Ther. 2019;27(2):365\u201379.","journal-title":"Mol Ther"},{"issue":"9","key":"4456_CR36","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/bjc.2014.122","volume":"110","author":"Y Feng","year":"2014","unstructured":"Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang W, Li L. MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. Br J Cancer. 2014;110(9):2300\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"4456_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.CAN-09-2021","volume":"70","author":"M Sachdeva","year":"2010","unstructured":"Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010;70(1):378\u201387.","journal-title":"Cancer Res"},{"issue":"8","key":"4456_CR38","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.7150\/jca.67977","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Shi J, Zhang N, Zheng X, Jin Y, Wen S, Hu W, Wu Y, Gao W. FSCN1 acts as a promising therapeutic target in the Blockade of tumor cell motility: a review of its function, mechanism, and clinical significance. J Cancer. 2022;13(8):2528\u201339.","journal-title":"J Cancer"},{"issue":"1","key":"4456_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ijc.34526","volume":"153","author":"C Ruggiero","year":"2023","unstructured":"Ruggiero C, Tamburello M, Rossini E, Zini S, Durand N, Cantini G, Cioppi F, Hantel C, Kiseljak-Vassiliades K, Wierman ME, et al. FSCN1 as a new druggable target in adrenocortical carcinoma. Int J Cancer. 2023;153(1):210\u201323.","journal-title":"Int J Cancer"},{"issue":"5","key":"4456_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41419-019-1574-5","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tian T, Li Z-Y, Wang C-Y, Deng R, Deng W-Y, Yang A-k, Chen Y-F, Li H. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma. Cell Death Dis. 2019;10(5):356.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4456_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12967-023-04225-0","volume":"21","author":"W Bai","year":"2023","unstructured":"Bai W, Ren J-S, Xia M, Zhao Y, Ding J-J, Chen X, Jiang Q. Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization. J Translational Med. 2023;21(1):555.","journal-title":"J Translational Med"},{"issue":"1","key":"4456_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12967-023-04146-y","volume":"21","author":"Z Li","year":"2023","unstructured":"Li Z, Tao Y, Gao Z, Peng S, Lai Y, Li K, Chen X, Huang H. SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. J Translational Med. 2023;21(1):303.","journal-title":"J Translational Med"},{"key":"4456_CR43","doi-asserted-by":"publisher","first-page":"215583","DOI":"10.1016\/j.canlet.2022.215583","volume":"532","author":"Y Shi","year":"2022","unstructured":"Shi Y, Xu Y, Xu Z, Wang H, Zhang J, Wu Y, Tang B, Zheng S, Wang K. TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression. Cancer Lett. 2022;532:215583.","journal-title":"Cancer Lett"},{"issue":"5","key":"4456_CR44","doi-asserted-by":"publisher","first-page":"100691","DOI":"10.1016\/j.jhepr.2023.100691","volume":"5","author":"C Gest","year":"2023","unstructured":"Gest C, Sena S, Dif L, Neaud V, Loesch R, Dugot-Senant N, Paysan L, Piquet L, Robbe T, Allain N, et al. Antagonism between wild-type and mutant \u03b2-catenin controls hepatoblastoma differentiation via fascin-1. JHEP Rep. 2023;5(5):100691.","journal-title":"JHEP Rep"},{"issue":"1","key":"4456_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-025-07443-0","volume":"16","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhang J, Li Y, Feng C, Shao C, Shi Y, Fang J. Engineered mesenchymal stem\/stromal cells against cancer. Cell Death Dis. 2025;16(1):113.","journal-title":"Cell Death Dis"},{"key":"4456_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2019.05.030","volume":"305","author":"F Zahednezhad","year":"2019","unstructured":"Zahednezhad F, Saadat M, Valizadeh H, Zakeri-Milani P, Baradaran B. Liposome and immune system interplay: challenges and potentials. J Controlled Release. 2019;305:194\u2013209.","journal-title":"J Controlled Release"},{"key":"4456_CR47","doi-asserted-by":"crossref","unstructured":"Chen Y, Shi Y, Tao Z. Fluorescence tracking of small extracellular vesicles in vivo. Pharmaceutics 2023, 15(9).","DOI":"10.3390\/pharmaceutics15092297"},{"issue":"1","key":"4456_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13287-022-02983-0","volume":"13","author":"F Sun","year":"2022","unstructured":"Sun F, Sun Y, Zhu J, Wang X, Ji C, Zhang J, Chen S, Yu Y, Xu W, Qian H. Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4. Stem Cell Res Ther. 2022;13(1):293.","journal-title":"Stem Cell Res Ther"},{"key":"4456_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2020.11.062","volume":"330","author":"S Kwon","year":"2021","unstructured":"Kwon S, Shin S, Do M, Oh BH, Song Y, Bui VD, Lee ES, Jo DG, Cho YW, Kim DH, et al. Engineering approaches for effective therapeutic applications based on extracellular vesicles. J Controlled Release: Official J Controlled Release Soc. 2021;330:15\u201330.","journal-title":"J Controlled Release: Official J Controlled Release Soc"},{"issue":"6","key":"4456_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41566-024-01391-5","volume":"18","author":"F Wang","year":"2024","unstructured":"Wang F, Zhong Y, Bruns O, Liang Y, Dai H. In vivo NIR-II fluorescence imaging for biology and medicine. Nat Photonics. 2024;18(6):535\u201347.","journal-title":"Nat Photonics"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:11:09Z","timestamp":1751382669000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4456"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04456-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work has been reported in line with the ARRIVE guidelines 2.0. Human CRC cell lines HCT116 and SW480 were purchased from Institute of Biochemistry and Cell Biology at the Chinese Academy of Sciences (China National Collection of Authenticated Cell Cultures). This agency confirmed that there was initial ethical approval for the collection of human cells with informed consent signed by donors. All animal experiments in the project entitled \u201cMiR-145 encapsulated hucMSC-derived small extracellular vesicles inhibit colorectal cancer growth and progression\u201d were approved by the Institutional Animal Care and Use Committee of Jiangsu University on March 14, 2024 (approval number: JSDX20240314003). Informed consent was acquired from patients with CRCs, and ethical approval was obtained from Ethics Committees of Affiliated Hospital of Jiangsu University (Title of study: Research on the role and mechanism of miR-145 in human lung and colorectal cancers; Reference number: KY2024K0404; Approval date: April 20, 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of AI usage"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}